SAVANNAH HAM: Open Payments
NPI 1487417309 · PERRY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 54 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $497 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $218 |
| Novo Nordisk Inc | 7 | $173 |
| Amgen Inc. | 11 | $151 |
| Astellas Pharma US Inc | 3 | $68 |
| Dexcom, Inc. | 3 | $64 |
| PFIZER INC. | 2 | $46 |
| ABBVIE INC. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Antares Pharma, Inc. | 2 | $40 |
| Edwards Lifesciences Corporation | 1 | $34 |
Products named: JARDIANCE, Ozempic, OTEZLA, Veozah, Dexcom G6 Transmitter, EVENITY, MOUNJARO, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
